Enzymatic Electrochemical Sensor for Real-Time Propofol Monitoring
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for monitoring propofol concentrations in patients undergoing anesthesia, such as HPLC and mass spectrometry, are not suitable for real-time, point-of-care applications due to their bulkiness, high costs, and requirement for complex sample preparation, limiting their utility in clinical settings.
Innovation Solution
Development of an enzyme-based electrochemical sensor using cytochrome P450 2B6 immobilized in a chitosan film with gold nanoparticles on a screen-printed electrode, which converts propofol into a quinone/quinol redox pair for simple electrochemical detection, avoiding electrode fouling and enabling continuous, real-time monitoring.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If HPLC or mass spectrometry is used for propofol detection, then measurement precision is improved, but device complexity and cost increase significantly
Solution Approach 1:
The patent replaces complex mechanical chromatographic systems (HPLC, GC-MS) with a simplified electrochemical sensing system. The sensor uses a modified electrode with cytochrome P450 enzyme immobilized in a chitosan film to catalyze propofol oxidation, generating an electrochemical signal that can be detected by a portable voltmeter, eliminating the need for bulky chromatography equipment.
Solution Approach 2:
The patent introduces cytochrome P450 2B6 enzyme as a biological intermediary that catalyzes the oxidation of propofol. This enzyme mediator transforms the difficult-to-detect propofol molecule into an electrochemically active species, enabling sensitive detection through simple voltammetry without requiring complex instrumentation.
2Measurement precision
If HPLC or mass spectrometry is used for propofol detection, then measurement precision is improved, but analysis time increases
Solution Approach 1:
The electrochemical sensor enables continuous real-time monitoring of propofol concentrations during anesthesia procedures. The sensor can be implanted in the patient and continuously measure propofol levels without requiring repeated blood draws and laboratory analysis, providing uninterrupted pharmacokinetic data throughout the surgical procedure.
Solution Approach 2:
The patent replaces time-consuming chromatographic separation and detection processes with immediate electrochemical detection. The enzyme-catalyzed oxidation reaction occurs instantly upon propofol contact with the sensor, providing immediate results without the minutes to hours required for HPLC or mass spectrometry analysis.
3Device complexity
If direct electrochemical measurement is used, then device complexity is reduced, but electrode fouling occurs
Solution Approach 1:
The patent uses cytochrome P450 2B6 enzyme as an intermediary catalyst that mediates the oxidation of propofol. Instead of direct electron transfer from propofol to the electrode (which causes fouling), the enzyme facilitates a controlled redox reaction that generates stable electrochemical signals without polymer formation on the electrode surface.
Solution Approach 2:
The patent modifies the electrode surface by immobilizing the enzyme in a chitosan film matrix, changing the chemical environment at the electrode interface. This enzymatic modification alters the reaction mechanism from direct propofol oxidation (fouling-prone) to enzyme-catalyzed oxidation (stable), maintaining electrode reliability over time.
4Reliability
If enzymatic detection is used, then electrode fouling is avoided, but specificity challenges arise
Solution Approach 1:
The patent employs cytochrome P450 2B6 enzyme with specific structural and functional properties that are locally optimized for propofol detection. The enzyme's active site is specifically configured to bind and oxidize propofol, providing high specificity. The chitosan film matrix further enhances this local specificity by creating a selective environment that favors propofol substrate access.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The sensor provides stable, real-time measurements of propofol concentrations with a limit of detection as low as 49 ng/ml and a linear response up to 1.4 µg/ml, demonstrating improved specificity and durability for clinical use.
Implementation Method 1
The sensor is based on an enzyme, in particular on cytochrome P450 2B6
Implementation Method 2
converts propofol into a quinone/quinol redox pair for simple electrochemical detection
Implementation Method 3
immobilized in a chitosan film with gold nanoparticles on a screen-printed electrode
Implementation Method 4
immobilized in a chitosan film
Implementation Method 5
simple electrochemical detection
Data Source
AI summary
An enzymatic electrochemical sensor for the detection of blood propofol is provided.